| Robert S Gorby, MD | |
|
530 South St, Suite 280, Greensburg, PA 15601-2775 | |
| (724) 832-1200 | |
| (724) 830-8518 |
| Full Name | Robert S Gorby |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 530 South St, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205836640 | NPI | - | NPPES |
| 0015387160007 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD045968L (Pennsylvania) | Primary |
| Entity Name | Westmoreland Allergy & Asthma Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912471616 PECOS PAC ID: 7911245873 Enrollment ID: O20190219001752 |
News Archive
Covalon Technologies Ltd. (the "Company" or "Covalon"), an advanced medical technologies company, today announced that further to its press release of August 16, 2013, it has completed, subject to final approval of the TSX Venture Exchange, a non-brokered private placement comprised of 750 units (the "Units") at a price of $1,000 per Unit for gross proceeds of $750,000. Each Unit consists of $1,000 principal amount of 12% senior secured convertible debenture (the "Debentures" and each a "Debenture") and 6,451 warrants (each, a "Warrant").
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced that is has been selected as a finalist in the 2010 Colorado Ethics in Business Alliance (CEBA) Awards, in the Samaritan Institute category honoring non-profits.
One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.
Researchers from the University of Sydney, Australia determined that patients with a sedentary lifestyle who engage in routine physical activities lower their risk of nonalcoholic fatty liver disease (NAFLD).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert S Gorby, MD 530 South St, Suite 280, Greensburg, PA 15601-2775 Ph: (724) 832-1200 | Robert S Gorby, MD 530 South St, Suite 280, Greensburg, PA 15601-2775 Ph: (724) 832-1200 |
News Archive
Covalon Technologies Ltd. (the "Company" or "Covalon"), an advanced medical technologies company, today announced that further to its press release of August 16, 2013, it has completed, subject to final approval of the TSX Venture Exchange, a non-brokered private placement comprised of 750 units (the "Units") at a price of $1,000 per Unit for gross proceeds of $750,000. Each Unit consists of $1,000 principal amount of 12% senior secured convertible debenture (the "Debentures" and each a "Debenture") and 6,451 warrants (each, a "Warrant").
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced that is has been selected as a finalist in the 2010 Colorado Ethics in Business Alliance (CEBA) Awards, in the Samaritan Institute category honoring non-profits.
One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.
Researchers from the University of Sydney, Australia determined that patients with a sedentary lifestyle who engage in routine physical activities lower their risk of nonalcoholic fatty liver disease (NAFLD).
› Verified 6 days ago